MUC4 is increased in high grade intraepithelial neoplasia in Barrett’s oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio

Background: Patients with Barrett’s oesophagus (BO) are at risk of oesophageal adenocarcinoma. Because the pattern of mucosal mucins changes during neoplastic progression, it may serve as a marker of intraepithelial neoplasia. Aims: To determine the expression pattern of mucins in neoplastic BO epithelium (high grade dysplasia) and correlate it with the expression of apoptosis markers Bax and Bcl-2. Methods: Thirty seven patients with BO were studied: 16 without intraepithelial neoplasia, six with high grade intraepithelial neoplasia (HGN), and 15 with infiltrating adenocarcinoma. Biopsies were obtained from squamous epithelium, Barrett’s epithelium, and (when present) foci of suspected HGN or adenocarcinoma. MUC1–4, MUC5AC, MUC5B, MUC6, Bax, and Bcl-2 mRNA were determined by semiquantitative RT-PCR. MUC2, MUC5AC, and MUC6 protein was determined by immunoblotting. Results: Mucin expression varied between neoplastic progression stages in BO. Mucin mRNA levels were low in squamous epithelium, except for MUC4, and were at least four times higher in BO and HGN (p<0.001), but less so in adenocarcinoma. MUC4 expression was significantly lower in BO than in normal squamous epithelium, whereas in HGN and adenocarcinoma, levels were significantly higher than in BO (p = 0.037). The Bax:Bcl-2 ratio was increased in HGN compared with BO (p = 0.04). MUC2, MUC5AC, and MUC6 protein values correlated with mRNA data. Conclusions: Mucin expression varies during the development of oesophageal adenocarcinoma in BO. MUC4 could serve as a tumour marker in this process. In contrast to animal studies, upregulation of MUC4 in HGN is associated with increased apoptosis, suggesting that MUC4 plays a minor role in apoptosis regulation in BO.

[1]  L. Shantz,et al.  Characterization of transgenic mice with widespread overexpression of spermine synthase. , 2004, The Biochemical journal.

[2]  S. Batra,et al.  Transcriptional regulation of human mucin MUC4 by bile acids in oesophageal cancer cells is promoter-dependent and involves activation of the phosphatidylinositol 3-kinase signalling pathway. , 2004, The Biochemical journal.

[3]  T. Hla,et al.  Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  C. A. Carraway,et al.  Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27kip, but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways , 2002, Oncogene.

[5]  A. Sonnenberg,et al.  Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma , 2002, American Journal of Gastroenterology.

[6]  J. Kleibeuker,et al.  Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype. , 2002, Human pathology.

[7]  J. Dekker,et al.  Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. , 2002, Human pathology.

[8]  J. Cameron,et al.  MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. , 2002, American journal of clinical pathology.

[9]  G. A. Meijer,et al.  Surveillance in Barrett's Oesophagus: a Critical Reappraisal , 2002, Scandinavian journal of gastroenterology. Supplement.

[10]  H. Friess,et al.  Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  F. Alameda,et al.  MUC4 expression is increased in dysplastic cervical disorders. , 2001, Human pathology.

[12]  C. Probert,et al.  Mucins in the gastrointestinal tract in health and disease. , 2001, Frontiers in bioscience : a journal and virtual library.

[13]  H. Höfler,et al.  Her-2/neu Gene Amplification, Elevated mRNA Expression, and Protein Overexpression in the Metaplasia-Dysplasia-Adenocarcinoma Sequence of Barrett’s Esophagus , 2001, Laboratory Investigation.

[14]  J. Jankowski,et al.  Surveillance for Barrett's oesophagus , 2001, BMJ : British Medical Journal.

[15]  Masanobu Komatsu,et al.  Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor , 2001, Oncogene.

[16]  J. Triboulet,et al.  Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus , 2000, International journal of cancer.

[17]  D. Alderson,et al.  Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study , 2000, Gut.

[18]  K. Carraway,et al.  Potentiation of metastasis by cell surface sialomucin complex (rat MUC4), a multifunctional anti‐adhesive glycoprotein , 2000, International journal of cancer.

[19]  M. Copin,et al.  From normal respiratory mucosa to epidermoid carcinoma: Expression of human mucin genes , 2000, International journal of cancer.

[20]  Mason,et al.  Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation , 1999, Histopathology.

[21]  L. Yee,et al.  Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killer cells. , 1999, Cancer research.

[22]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[23]  J. Goldblum,et al.  Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. , 1999, Gastrointestinal endoscopy.

[24]  G. Niehans,et al.  Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps , 1999, International journal of cancer.

[25]  Y. Nakanuma,et al.  Expression of MUC2, MUC5AC and MUC6 apomucins in carcinoma, dysplasia and non‐dysplastic epithelia of the gallbladder , 1999, Pathology international.

[26]  R. Sampliner,et al.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus , 1998, American Journal of Gastroenterology.

[27]  C. A. Carraway,et al.  Reversible Disruption of Cell-Matrix and Cell-Cell Interactions by Overexpression of Sialomucin Complex* , 1997, The Journal of Biological Chemistry.

[28]  T. Hattori,et al.  Reflux of duodenal or gastro‐duodenal contents induces esophageal carcinoma in rats , 1996, International journal of cancer.

[29]  A. Sonnenberg,et al.  Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components , 1995, The Journal of cell biology.

[30]  J. Jankowski,et al.  Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus. , 1992, Gut.

[31]  G Van Belle,et al.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.

[32]  R. R. Smith,et al.  The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. , 1987, American journal of clinical pathology.

[33]  D. Skinner,et al.  Dysplasia in Barrett's esophagus , 2004, Journal of Cancer Research and Clinical Oncology.

[34]  J. Reynolds,et al.  Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation. , 2003, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[35]  C. A. Carraway,et al.  Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive. , 2002, Progress in nucleic acid research and molecular biology.

[36]  A. Sonnenberg,et al.  Episialin ( MUC 1 ) Overexpression Inhibits Integrin-mediated Cell Adhesion to Extracellular Matrix Components , 2002 .

[37]  P. Dítě,et al.  [Barrett's esophagus]. , 2000, Bratislavske lekarske listy.

[38]  M. Vieth,et al.  Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus , 1999, Journal of Cancer Research and Clinical Oncology.